Innovating Diagnostics. Empowering Care.

Portfolio of Clinical Solutions

Diagnostic & Imaging Consultancy
Comprehensive planning, technology acquisition, and workflow optimization for radiology and nuclear medicine units.

Expert PET/CT & Nuclear Medicine Reporting
Our consortium delivers premium PET/CT and Nuclear Medicine reporting services designed for both NHS trusts and...

AI-Driven Imaging Software
We are currently developing an innovative Mobile Radiopharmacy and Theragnostic Solutions platform, which...
About rAIdionostics
- Bespoke AI Development for Diagnostics
- Subspecialty Teleradiology
- Clinical Training & Mentorship
- Appraisal & Training for Healthcare Professionals
- Research Collaboration

At rAIdionostics, we bring together clinical expertise, cutting-edge imaging technology, and a deep commitment to quality to transform how diagnostic and theragnostic services are delivered. Our mission is to provide intelligent, sustainable solutions across nuclear medicine, radiology, and molecular imaging—designed not just for today, but for the future of patient care.
Najeeb Ahmed
Medical Director
Case Studies & Pilot Projects
Case Study 2
Transforming Hybrid Imaging Services with End-to-End Clinical Support
rAIdionostics responded by providing expert interpretation of both SPECT and PET/CT studies, utilising advanced hybrid imaging reporting tools to deliver structured, clinically meaningful reports.
But our support extended well beyond reporting. We provided full ARSAC-level supervisory input, ensuring not only regulatory compliance but also the establishment of a clinically robust and safe service. Unlike transactional providers, our focus is on forming long-term, collaborative partnerships—embedding into local workflows, supporting multidisciplinary teams, and raising the overall standard of reporting.
This approach is particularly critical in nuclear medicine, where clinician oversight before and during image acquisition plays a far more integral role compared to conventional radiology workflows.
The outcome was clear: greater clinical confidence, improved report clarity, and a stronger, more resilient imaging service. At rAIdionostics, our commitment to expertise, innovation, and sustainable collaboration continues to reshape expectations for nuclear medicine reporting.
Case study 3
Recognising this gap, we are in the process of developing an agile, community-based ultrasound service aimed at bringing diagnostics closer to patients. The goal is simple: make ultrasound more accessible, flexible, and responsive to local needs.
The idea began with a question from GPs and patients alike: why must people travel long distances or wait weeks for a simple scan? For many, attending hospital-based imaging appointments involves lengthy journeys, unreliable public transport, or needing to take time off work or arrange for carers — all for a 15-minute procedure.
We are currently developing a pilot project in conjunction with primary care colleagues in a region where distances are a major barrier. Early feedback from clinicians and patients has been overwhelmingly positive, with potentially reduced wait times and improved convenience noted as likely key benefits.
As the service evolves and get deployed, we will work to ensure it meets all clinical, digital, and safety standards while remaining adaptable to different communities. By addressing regional inequalities in access to care, this project has the potential to change how — and where — ultrasound is delivered.
Why Choose Us ?

Clinician-led and evidence-driven

Trusted by academic and NHS collaborators

AI-integrated solutions

Preclinical PET Research to Clinical Delivery
Transforming Hybrid Imaging Services with End-to-End Clinical Support
A partner institution reached out to us following persistent concerns over the quality and consistency of their nuclear medicine and PET/CT reporting. A particular challenge was the accurate interpretation of hybrid cross-sectional imaging, especially SPECT/CT, where nuanced clinical judgement is essential.
rAIdionostics responded by providing expert interpretation of both SPECT and PET/CT studies, utilising advanced hybrid imaging reporting tools to deliver structured, clinically meaningful reports.
But our support extended well beyond reporting. We provided full ARSAC-level supervisory input, ensuring not only regulatory compliance but also the establishment of a clinically robust and safe service. Unlike transactional providers, our focus is on forming long-term, collaborative partnerships—embedding into local workflows, supporting multidisciplinary teams, and raising the overall standard of reporting.
This approach is particularly critical in nuclear medicine, where clinician oversight before and during image acquisition plays a far more integral role compared to conventional radiology workflows.
The outcome was clear: greater clinical confidence, improved report clarity, and a stronger, more resilient imaging service. At rAIdionostics, our commitment to expertise, innovation, and sustainable collaboration continues to reshape expectations for nuclear medicine reporting.
Why Work With Us?
Flexible working models
Research-driven innovation culture
Competitive compensation and development support
The Management Team

Startups
Designer
- Phone:+1 (859) 254-6589
- Email:info@example.com

Justin Hammer
Founder/ CEO
- Phone:+1 (859) 254-6589
- Email:info@example.com

Ashley Hardy
VP Sales and Marketing
- Phone:+1 (859) 254-6589
- Email:info@example.com

Clark Roberts
Chief Finance Officer
- Phone:+1 (859) 254-6589
- Email:info@example.com
Our Partners





Coming Soon Feedback from NHS partners and international collaborators

News & Updates

Setting Up a Theragnostic Unit Regulatory Hurdles and Solutions
Theragnostics, the combination of therapy and diagnostics, is a rapidly evolving field in modern medicine that merges personalized treatment with real-time monitoring.

AI vs Human Insight in PET/CT Interpretation
In recent years, artificial intelligence (AI) has become a buzzword across multiple industries, and healthcare is no exception. One area where AI has made significant strides is in medical imaging,

The Future of Mobile Radiopharmacy in the NHS
The National Health Service (NHS) has long been at the forefront of medical innovation, particularly when it comes to adopting cutting-edge technologies to improve patient care.